News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
EPIQ Capital Group, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/11/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
| 02/13/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 12/22/2022 |
SC 13D/A
| EPIQ Capital Group, LLC reports a 2.5% stake in Lucira Health, Inc. |
| 12/16/2022 |
4
| EPIQ Capital Group, LLC (10% Owner) has filed a Form 4 on Lucira Health, Inc.|
Txns:
| Disposed of 3,461,764 shares
@ $0
Disposed of 3,754,084 shares
@ $0
Disposed of 5,173,026 shares
@ $0
Disposed of 735,475 shares
@ $0
Acquired 256,742 shares
@ $0
Acquired 725,675 shares
@ $0 |
|
| 11/09/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/09/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/18/2021 |
4
| EPIQ Capital Group, LLC (Managing member of 10% owner) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Bought 4,000 shares
@ $22.5746, valued at
$90.3k
Bought 7,135 shares
@ $22.3804, valued at
$159.7k
|
|
| 11/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/30/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/03/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/12/2021 |
SC 13D
| EPIQ Capital Group, LLC reports a 34.3% stake in Lucira Health, Inc. |
| 02/09/2021 |
4
| EPIQ Capital Group, LLC (10% Owner) has filed a Form 4 on Lucira Health, Inc.|
Txns:
| Converted 32,176 shares
@ $0
Converted 3,754,084 shares
@ $0
Converted 5,173,026 shares
@ $0
Converted 735,475 shares
@ $17, valued at
$12.5M
Bought 3,461,764 shares
@ $17, valued at
$58.8M
Converted 32,176 options to buy
@ $0
Converted 3,754,084 options to buy
@ $0
Converted 5,173,026 options to buy
@ $0
Converted 735,475 options to buy
@ $17, valued at
$12.5M
|
|
| 02/04/2021 |
3
| EPIQ Capital Group, LLC (Managing Mbr of 10% Owners) has filed a Form 3 on Lucira Health, Inc. |
| 02/01/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/06/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/27/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/18/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 06/18/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/18/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/15/2020 |
4
| EPIQ Capital Group, LLC (IA/Managing Member of 10% Owne) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Bought 6,600 shares
@ $44.32, valued at
$292.5k
Bought 2,440 shares
@ $44.06, valued at
$107.5k
|
|
| 06/11/2020 |
4
| EPIQ Capital Group, LLC (Managing Member of 10% owner) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Converted 2,149,292 shares
@ $0
Converted 3,394,948 shares
@ $0
Bought 2,500,000 shares
@ $14, valued at
$35M
Bought 220,000 shares
@ $14, valued at
$3.1M
Converted 2,149,292 preferred shares
@ $0
Converted 3,394,948 preferred shares
@ $0 |
|
| 06/04/2020 |
3
| EPIQ Capital Group, LLC (Managing Member of 10% owner) has filed a Form 3 on Applied Molecular Transport Inc. |
| 05/22/2020 |
4
| EPIQ Capital Group, LLC (IA/Managing Member of 10% Owne) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Bought 5,668 shares
@ $58, valued at
$328.7k
Bought 417 shares
@ $57.22, valued at
$23.9k
Bought 520 shares
@ $55.8, valued at
$29k
Bought 2,085 shares
@ $55.9, valued at
$116.6k
|
|
| 01/31/2020 |
4
| EPIQ Capital Group, LLC (IA/Managing Member of 10% Owne) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Disposed of 4,338 shares
@ $54.3, valued at
$235.6k
|
|
| 11/29/2019 |
4/A
| EPIQ Capital Group, LLC (IA/Managing Member of 10% owne) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Bought 600 shares
@ $25.69, valued at
$15.4k
Bought 2,310 shares
@ $25.69, valued at
$59.3k
Bought 420 shares
@ $24.8685, valued at
$10.4k
Bought 1,635 shares
@ $24.8685, valued at
$40.7k
|
|
| 11/29/2019 |
4/A
| EPIQ Capital Group, LLC (IA/Managing Member of 10% owne) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Bought 700 shares
@ $26.3714, valued at
$18.5k
Bought 2,100 shares
@ $26.4952, valued at
$55.6k
|
|
| 11/29/2019 |
4/A
| EPIQ Capital Group, LLC (IA/Managing Member of 10% owne) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Bought 4,350 shares
@ $26.41, valued at
$114.9k
Bought 4,170 shares
@ $27.58, valued at
$115k
Bought 80 shares
@ $27.05, valued at
$2.2k
|
|
| 11/29/2019 |
3/A
| EPIQ Capital Group, LLC (IA/Managing Member 10% owner) has filed a Form 3/A on Cortexyme, Inc. |
| 08/21/2019 |
4
| EPIQ Capital Group, LLC (IA/Managing Member 10% owner) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Bought 600 shares
@ $25.69, valued at
$15.4k
Bought 2,310 shares
@ $25.69, valued at
$59.3k
Bought 420 shares
@ $24.8685, valued at
$10.4k
Bought 1,635 shares
@ $24.8685, valued at
$40.7k
|
|
|
|
|